Extension Study to Evaluate the Long-Term Safety and Tolerability of Oral Atogepant for the Prevention of Migraine in Participants With Episodic Migraine

Clinical trial NCT03939312 · COMPLETED

Trial details

NCT number: NCT03939312
Sponsor: Allergan
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Episodic Migraine

Start date: 2019-05-06
Primary completion: 2021-03-31
Enrollment: 685

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.